Literature DB >> 19029248

Biochemical and structural properties of mouse kynurenine aminotransferase III.

Qian Han1, Howard Robinson, Tao Cai, Danilo A Tagle, Jianyong Li.   

Abstract

Kynurenine aminotransferase III (KAT III) has been considered to be involved in the production of mammalian brain kynurenic acid (KYNA), which plays an important role in protecting neurons from overstimulation by excitatory neurotransmitters. The enzyme was identified based on its high sequence identity with mammalian KAT I, but its activity toward kynurenine and its structural characteristics have not been established. In this study, the biochemical and structural properties of mouse KAT III (mKAT III) were determined. Specifically, mKAT III cDNA was amplified from a mouse brain cDNA library, and its recombinant protein was expressed in an insect cell protein expression system. We established that mKAT III is able to efficiently catalyze the transamination of kynurenine to KYNA and has optimum activity at relatively basic conditions of around pH 9.0 and at relatively high temperatures of 50 to 60 degrees C. In addition, mKAT III is active toward a number of other amino acids. Its activity toward kynurenine is significantly decreased in the presence of methionine, histidine, glutamine, leucine, cysteine, and 3-hydroxykynurenine. Through macromolecular crystallography, we determined the mKAT III crystal structure and its structures in complex with kynurenine and glutamine. Structural analysis revealed the overall architecture of mKAT III and its cofactor binding site and active center residues. This is the first report concerning the biochemical characteristics and crystal structures of KAT III enzymes and provides a basis toward understanding the overall physiological role of mammalian KAT III in vivo and insight into regulating the levels of endogenous KYNA through modulation of the enzyme in the mouse brain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19029248      PMCID: PMC2630683          DOI: 10.1128/MCB.01272-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

Review 1.  The manifold of vitamin B6 dependent enzymes.

Authors:  G Schneider; H Käck; Y Lindqvist
Journal:  Structure       Date:  2000-01-15       Impact factor: 5.006

2.  wARP: improvement and extension of crystallographic phases by weighted averaging of multiple-refined dummy atomic models.

Authors:  A Perrakis; T K Sixma; K S Wilson; V S Lamzin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-07-01

3.  The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.

Authors:  C Hilmas; E F Pereira; M Alkondon; A Rassoulpour; R Schwarcz; E X Albuquerque
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

4.  pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I.

Authors:  Qian Han; Junsuo Li; Jianyong Li
Journal:  Eur J Biochem       Date:  2004-12

5.  Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor.

Authors:  P J Birch; C J Grossman; A G Hayes
Journal:  Eur J Pharmacol       Date:  1988-09-01       Impact factor: 4.432

6.  Early kynurenergic impairment in Huntington's disease and in a transgenic animal model.

Authors:  P Guidetti; P H Reddy; D A Tagle; R Schwarcz
Journal:  Neurosci Lett       Date:  2000-04-14       Impact factor: 3.046

7.  Increased cortical kynurenate content in schizophrenia.

Authors:  R Schwarcz; A Rassoulpour; H Q Wu; D Medoff; C A Tamminga; R C Roberts
Journal:  Biol Psychiatry       Date:  2001-10-01       Impact factor: 13.382

8.  Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats.

Authors:  Trevor W Stone
Journal:  Eur J Neurosci       Date:  2007-04-25       Impact factor: 3.386

9.  Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice.

Authors:  Ping Yu; Nicholas A Di Prospero; Michael T Sapko; Tao Cai; Amy Chen; Miguel Melendez-Ferro; Fu Du; William O Whetsell; Paolo Guidetti; Robert Schwarcz; Danilo A Tagle
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

10.  Identification of a mitochondrial form of kynurenine aminotransferase/glutamine transaminase K from rat brain.

Authors:  P Malherbe; D Alberati-Giani; C Köhler; A M Cesura
Journal:  FEBS Lett       Date:  1995-06-26       Impact factor: 4.124

View more
  34 in total

1.  Biochemical and structural characterization of mouse mitochondrial aspartate aminotransferase, a newly identified kynurenine aminotransferase-IV.

Authors:  Qian Han; Howard Robinson; Tao Cai; Danilo A Tagle; Jianyong Li
Journal:  Biosci Rep       Date:  2011-10       Impact factor: 3.840

2.  Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior.

Authors:  Michelle C Potter; Greg I Elmer; Richard Bergeron; Edson X Albuquerque; Paolo Guidetti; Hui-Qiu Wu; Robert Schwarcz
Journal:  Neuropsychopharmacology       Date:  2010-03-24       Impact factor: 7.853

3.  Comparative enzymology of (2S,4R)4-fluoroglutamine and (2S,4R)4-fluoroglutamate.

Authors:  Arthur J L Cooper; Boris F Krasnikov; John T Pinto; Hank F Kung; Jianyong Li; Karl Ploessl
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2012-05-19       Impact factor: 2.231

Review 4.  Structure, expression, and function of kynurenine aminotransferases in human and rodent brains.

Authors:  Qian Han; Tao Cai; Danilo A Tagle; Jianyong Li
Journal:  Cell Mol Life Sci       Date:  2009-10-15       Impact factor: 9.261

Review 5.  Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation.

Authors:  Troy D Hubbard; Iain A Murray; Gary H Perdew
Journal:  Drug Metab Dispos       Date:  2015-06-03       Impact factor: 3.922

6.  Crystal structure-based selective targeting of the pyridoxal 5'-phosphate dependent enzyme kynurenine aminotransferase II for cognitive enhancement.

Authors:  Franca Rossi; Casazza Valentina; Silvia Garavaglia; Korrapati V Sathyasaikumar; Robert Schwarcz; Shin-Ichi Kojima; Keisuke Okuwaki; Shin-Ichiro Ono; Yasushi Kajii; Menico Rizzi
Journal:  J Med Chem       Date:  2010-08-12       Impact factor: 7.446

Review 7.  Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia.

Authors:  Ikwunga Wonodi; Robert Schwarcz
Journal:  Schizophr Bull       Date:  2010-02-10       Impact factor: 9.306

Review 8.  Lysine metabolism in mammalian brain: an update on the importance of recent discoveries.

Authors:  André Hallen; Joanne F Jamie; Arthur J L Cooper
Journal:  Amino Acids       Date:  2013-09-17       Impact factor: 3.520

9.  Thermal stability, pH dependence and inhibition of four murine kynurenine aminotransferases.

Authors:  Qian Han; Tao Cai; Danilo A Tagle; Jianyong Li
Journal:  BMC Biochem       Date:  2010-05-19       Impact factor: 4.059

Review 10.  α-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and inborn errors of the urea cycle.

Authors:  Arthur J L Cooper; Tomiko Kuhara
Journal:  Metab Brain Dis       Date:  2013-11-14       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.